ESC 365 - Duration of blood pressure treatment and risk of major cardiovascular events

ESC Professional Premium Access

Duration of blood pressure treatment and risk of major cardiovascular events

Session: Late-Breaking Clinical Science: new treatments and biomarkers in hypertension

Topic: Pharmacotherapy

Speaker: Professor K. Rahimi (Oxford, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Kazem Rahimi

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

9 presentations

4 followers

3 more presentations in this session

Benefit-harm trade-offs of intensive blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of six pivotal randomized controlled trials.

Speaker: Doctor X. Guo (Shenyang, CN)

ADEL: A population-based study of clinical outcomes of aldosterone dysregulation

Speaker: Professor R. Thomsen (Aarhus, DK)

Sacubitril/Allisartan in hyperuricemia

Speaker: Doctor W. Zhang (Shanghai, CN)

Access the full session

Late-Breaking Clinical Science: new treatments and biomarkers in hypertension

Speakers: Professor K. Rahimi, Doctor X. Guo, Professor R. Thomsen, Doctor W. Zhang

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources